Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 November 2006

Heart. Published Online First: 18 May 2006. doi:10.1136/hrt.2005.082560
Copyright © 2006 BMJ Publishing Group Ltd & British Cardiovascular Society

Original articles

Short-term statin therapy improves endothelial function and neurohormonal imbalance in normocholesteraemic patients with non-ischaemic heart failure

Christopher H Strey 1, Joanna M Young 2, John H Lainchbury 2, Christopher M Frampton 2, M Gary Nicholls 3, A Mark Richards 2 and Russell S Scott 2*

1 Addenbrooke's Hospital, United Kingdom
2 Christchurch Hospital and Christchurch School of Medicine and Health Sciences, New Zealand
3 United Arab Emirates University, United Arab Emirates

* To whom correspondence should be addressed. E-mail: russel.scott{at}chmeds.ac.nz.

Accepted 9 May 2006


Abstract

Aims: To investigate the effect of short-term statin therapy on impaired endothelium-dependent vasodilatation and hemodynamic abnormalities typically occurring in chronic heart failure (CHF).

Methods: In a double-blind, cross-over study we measured endothelium-dependent vasodilatation in conduit and resistance vessels of 23 patients with non-ischemic CHF after 6 weeks placebo and 40mg atorvastatin therapy. The hemodynamic impact was assessed by cardioendocrine hormones, echocardiography and clinical indicators of CHF.

Results: Cholesterol levels were population average (LDL 3.56±0.16mmol/L, triglycerides 1.70±0.20 mmol/L, HDL 1.17±0.07mmol/L). In resistance vessels, the area under the curve ratio during acetylcholine infusion increased from 9.2±1.9 on placebo to 12.2±2.1 on statin therapy (p<0.01). This improvement was reversed during co-infusion with the nitric oxide antagonist L-NMMA. In conduit arteries, flow mediated dilation increased from 5.64±0.88% on placebo to 6.83±0.97% on statin therapy (p<0.05). Endothelium-independent vasodilatation did not change (p=0.45 for conduit and p=0.68 for resistance vessels). Endothelin-1 and atrial natriuretic peptide (ANP) decreased from 1.57±0.08 and 51.3±1.0 on placebo to 1.42±0.09pg/ml (p<0.05) and 42.1±7.5pmol/L (p<0.05) on statin therapy.

Conclusions: In patients with non-ischemic CHF and population average cholesterol levels short-term statin therapy improves endothelial function in conduit- and resistance vessels and lowers plasma endothelin-1 and ANP levels.

Keywords: brachial ultrasound, endothelial function, forearm plethysmography, heart failure, statin therapy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Paulsen, L., Holm, C., Bech, J. N., Starklint, J., Pedersen, E. B. (2008). Effects of statins on renal sodium and water handling: Acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans. Nephrol Dial Transplant 23: 1556-1561 [Abstract] [Full Text]  
  • Leite-Moreira, A F, Castro-Chaves, P (2006). Heart failure: statins for all?. Heart 92: 1537-1538 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.